[1]
M. S. S. Vivek and K. C. Chandaliya, “Semaglutide salt versus base formulations: a regulatory and pharmacovigilance imperative”, Int J Basic Clin Pharmacol, vol. 15, no. 3, pp. 594–595, Apr. 2026.